Needham analyst Mike Matson reiterated a Hold rating on Boston Scientific (NYSE: BSX).The analyst commented: "BSX's 4Q24 revenue and EPS ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE